[HTML][HTML] The clinical application of growth hormone and its biological and molecular mechanisms in assisted reproduction

P Pan, X Huang - International Journal Of Molecular Sciences, 2022 - mdpi.com
Growth hormone (GH) has been used as a co-gonadotrophin in assisted reproduction,
particularly in poor ovarian responders. The application of GH has been alleged to activate …

Total gonadotropin dose did not affect euploid blastocyst rates: an analysis of more than 19,000 oocytes

J Shuai, W Liu, S Wan, Q Chen, Q Zhang… - Journal of Assisted …, 2024 - Springer
Background To evaluate whether increasing total gonadotropin (Gn) dose is associated with
changes in euploid blastocyst rate in preimplantation genetic testing (PGT) oocytes …

[HTML][HTML] Growth hormone supplementation during ovarian stimulation in women with advanced maternal age undergoing preimplantation genetic testing for …

Y Sui, M Xiao, J Fu, L Li, Y Xu, C Lei, X Sun - Journal of Ovarian Research, 2023 - Springer
Background Studies have shown that supplementation with recombinant human GH (rh-GH)
during ovarian stimulation (OS) may improve the ovarian response and clinical outcomes of …

[HTML][HTML] Effect of growth hormone cotreatment in sub-fertile women≥ 40 years: a meta-analysis

M Elkalyoubi, L Schindler… - Reproduction and Fertility, 2023 - raf.bioscientifica.com
Treatment of sub-fertile women aged≥ 40 years old (advanced maternal age (AMA)) is
challenging. Co-treatment with growth hormone (GH) is suggested to improve reproductive …

The effect of growth hormone on low-prognosis patients: a retrospective study based on POSEIDON criteria

Q Li, Y Zhang, F Xiong, H Zheng, Y Gu, Y Zhu - 2023 - researchsquare.com
Objective: To investigate the effect of growth hormone on low-prognosis patients who were
diagnosed by POSEIDON criteria. Methods: Poor ovarian reserve patients were included if …